<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Drug Response Prediction</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: white;
            display: flex;
            justify-content: center;
            align-items: center;
            min-height: 100vh;
            padding: 40px 20px;
        }
        
        .container {
            width: 960px;
            padding: 35px 45px;
            background: white;
        }
        
        .title {
            font-size: 20px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 25px;
            text-align: center;
        }
        
        .features-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 15px;
            margin-bottom: 50px;
        }
        
        .feature-card {
            background: #f8fbff;
            border: 2px solid #1E64C8;
            border-radius: 10px;
            padding: 15px 18px;
            transition: all 0.3s;
        }
        
        .feature-card:hover {
            transform: translateY(-3px);
            box-shadow: 0 6px 20px rgba(30, 100, 200, 0.2);
        }
        
        .feature-title {
            font-size: 17px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 8px;
        }
        
        .feature-desc {
            font-size: 16px;
            color: #333;
            line-height: 1.5;
        }
        
        .detail-section {
            margin-bottom: 50px;
            padding: 30px;
            background: #f9f9f9;
            border-radius: 15px;
            border-left: 5px solid #1E64C8;
        }
        
        .detail-section h2 {
            font-size: 22px;
            color: #1E64C8;
            margin-bottom: 20px;
            font-weight: 700;
        }
        
        .detail-section p {
            font-size: 16px;
            color: #333;
            line-height: 1.8;
            margin-bottom: 15px;
        }
        
        .diagram {
            background: white;
            border: 2px solid #1E64C8;
            border-radius: 10px;
            padding: 20px;
            margin: 20px 0;
        }
        
        .diagram-title {
            font-size: 16px;
            font-weight: 600;
            color: #1E64C8;
            text-align: center;
            margin-bottom: 15px;
        }
        
        svg {
            display: block;
            margin: 0 auto;
        }
        
        .key-points {
            background: #e8f4ff;
            padding: 20px;
            border-radius: 8px;
            margin-top: 15px;
        }
        
        .key-points h3 {
            font-size: 18px;
            color: #1E64C8;
            margin-bottom: 12px;
            font-weight: 600;
        }
        
        .key-points ul {
            margin-left: 25px;
        }
        
        .key-points li {
            font-size: 15px;
            color: #333;
            line-height: 1.7;
            margin-bottom: 8px;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="title">Drug Response Prediction</div>
        
        <div class="features-grid">
            <div class="feature-card">
                <div class="feature-title">Sensitivity Prediction</div>
                <div class="feature-desc">Predicting drug effectiveness</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Resistance Markers</div>
                <div class="feature-desc">Identifying resistance mechanisms</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Combination Effects</div>
                <div class="feature-desc">Drug synergy and antagonism</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Pharmacogenomics</div>
                <div class="feature-desc">Genetic variants affecting drug response</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Clinical Trials</div>
                <div class="feature-desc">Integration in precision medicine trials</div>
            </div>
        </div>

        <!-- Detailed Sections -->
        
        <!-- 1. Sensitivity Prediction -->
        <div class="detail-section">
            <h2>1. Sensitivity Prediction</h2>
            <p>Drug sensitivity prediction utilizes machine learning algorithms to forecast how effectively a particular drug will work against cancer cells or pathogens based on genomic, transcriptomic, and proteomic data. This approach enables personalized treatment selection by identifying patients most likely to benefit from specific therapeutics.</p>
            
            <div class="diagram">
                <div class="diagram-title">Drug Sensitivity Prediction Workflow</div>
                <svg width="800" height="300" viewBox="0 0 800 300">
                    <!-- Patient Data -->
                    <rect x="20" y="50" width="140" height="80" fill="#e8f4ff" stroke="#1E64C8" stroke-width="2" rx="5"/>
                    <text x="90" y="85" text-anchor="middle" font-size="14" font-weight="bold" fill="#1E64C8">Patient Data</text>
                    <text x="90" y="105" text-anchor="middle" font-size="12" fill="#333">Genomic</text>
                    <text x="90" y="120" text-anchor="middle" font-size="12" fill="#333">Transcriptomic</text>
                    
                    <!-- Arrow -->
                    <path d="M 160 90 L 220 90" stroke="#1E64C8" stroke-width="2" fill="none" marker-end="url(#arrowhead)"/>
                    
                    <!-- ML Model -->
                    <rect x="220" y="50" width="140" height="80" fill="#1E64C8" stroke="#1E64C8" stroke-width="2" rx="5"/>
                    <text x="290" y="85" text-anchor="middle" font-size="14" font-weight="bold" fill="white">ML Model</text>
                    <text x="290" y="105" text-anchor="middle" font-size="12" fill="white">Random Forest</text>
                    <text x="290" y="120" text-anchor="middle" font-size="12" fill="white">Deep Learning</text>
                    
                    <!-- Arrow -->
                    <path d="M 360 90 L 420 90" stroke="#1E64C8" stroke-width="2" fill="none" marker-end="url(#arrowhead)"/>
                    
                    <!-- Prediction -->
                    <rect x="420" y="50" width="140" height="80" fill="#e8f4ff" stroke="#1E64C8" stroke-width="2" rx="5"/>
                    <text x="490" y="85" text-anchor="middle" font-size="14" font-weight="bold" fill="#1E64C8">Prediction</text>
                    <text x="490" y="105" text-anchor="middle" font-size="12" fill="#333">IC50 Value</text>
                    <text x="490" y="120" text-anchor="middle" font-size="12" fill="#333">Response Score</text>
                    
                    <!-- Arrow -->
                    <path d="M 560 90 L 620 90" stroke="#1E64C8" stroke-width="2" fill="none" marker-end="url(#arrowhead)"/>
                    
                    <!-- Treatment Decision -->
                    <rect x="620" y="50" width="140" height="80" fill="#4CAF50" stroke="#2E7D32" stroke-width="2" rx="5"/>
                    <text x="690" y="85" text-anchor="middle" font-size="14" font-weight="bold" fill="white">Treatment</text>
                    <text x="690" y="105" text-anchor="middle" font-size="12" fill="white">Decision</text>
                    
                    <!-- Training Data -->
                    <rect x="220" y="180" width="140" height="60" fill="#fff3cd" stroke="#856404" stroke-width="2" rx="5"/>
                    <text x="290" y="205" text-anchor="middle" font-size="12" font-weight="bold" fill="#856404">Training Data</text>
                    <text x="290" y="225" text-anchor="middle" font-size="11" fill="#856404">Cell line responses</text>
                    
                    <!-- Arrow from training to model -->
                    <path d="M 290 180 L 290 130" stroke="#856404" stroke-width="2" fill="none" marker-end="url(#arrowhead2)"/>
                    
                    <!-- Arrowhead definitions -->
                    <defs>
                        <marker id="arrowhead" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <polygon points="0 0, 10 3, 0 6" fill="#1E64C8" />
                        </marker>
                        <marker id="arrowhead2" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <polygon points="0 0, 10 3, 0 6" fill="#856404" />
                        </marker>
                    </defs>
                </svg>
            </div>
            
            <div class="key-points">
                <h3>Key Applications:</h3>
                <ul>
                    <li><strong>Cancer Treatment Selection:</strong> Predicting response to chemotherapy, targeted therapy, and immunotherapy based on tumor molecular profiles</li>
                    <li><strong>IC50 Prediction:</strong> Estimating the half-maximal inhibitory concentration to determine optimal drug dosing</li>
                    <li><strong>Biomarker Discovery:</strong> Identifying genomic features (mutations, gene expression patterns) that correlate with drug sensitivity</li>
                    <li><strong>Patient Stratification:</strong> Classifying patients into responder and non-responder groups before treatment initiation</li>
                </ul>
            </div>
        </div>

        <!-- 2. Resistance Markers -->
        <div class="detail-section">
            <h2>2. Resistance Markers</h2>
            <p>Resistance markers are molecular indicators that signal a patient's tumor or pathogen may not respond to specific drugs. Understanding resistance mechanisms enables clinicians to avoid ineffective treatments and select alternative therapeutic strategies. These markers can be genetic mutations, gene amplifications, or expression changes that confer drug resistance.</p>
            
            <div class="diagram">
                <div class="diagram-title">Common Resistance Mechanisms</div>
                <svg width="800" height="350" viewBox="0 0 800 350">
                    <!-- Central Drug -->
                    <circle cx="400" cy="175" r="40" fill="#1E64C8" stroke="#0d47a1" stroke-width="2"/>
                    <text x="400" y="180" text-anchor="middle" font-size="14" font-weight="bold" fill="white">Drug</text>
                    
                    <!-- Resistance Mechanism 1: Target Mutation -->
                    <rect x="100" y="30" width="150" height="70" fill="#ffcdd2" stroke="#c62828" stroke-width="2" rx="5"/>
                    <text x="175" y="55" text-anchor="middle" font-size="13" font-weight="bold" fill="#c62828">Target Mutation</text>
                    <text x="175" y="75" text-anchor="middle" font-size="11" fill="#333">e.g., EGFR T790M</text>
                    <text x="175" y="90" text-anchor="middle" font-size="11" fill="#333">in lung cancer</text>
                    <path d="M 250 65 L 365 150" stroke="#c62828" stroke-width="2" stroke-dasharray="5,5"/>
                    
                    <!-- Resistance Mechanism 2: Efflux Pumps -->
                    <rect x="550" y="30" width="150" height="70" fill="#ffcdd2" stroke="#c62828" stroke-width="2" rx="5"/>
                    <text x="625" y="55" text-anchor="middle" font-size="13" font-weight="bold" fill="#c62828">Efflux Pumps</text>
                    <text x="625" y="75" text-anchor="middle" font-size="11" fill="#333">ABC transporters</text>
                    <text x="625" y="90" text-anchor="middle" font-size="11" fill="#333">↑ Drug export</text>
                    <path d="M 550 65 L 435 150" stroke="#c62828" stroke-width="2" stroke-dasharray="5,5"/>
                    
                    <!-- Resistance Mechanism 3: Bypass Signaling -->
                    <rect x="100" y="250" width="150" height="70" fill="#ffcdd2" stroke="#c62828" stroke-width="2" rx="5"/>
                    <text x="175" y="275" text-anchor="middle" font-size="13" font-weight="bold" fill="#c62828">Bypass Signaling</text>
                    <text x="175" y="295" text-anchor="middle" font-size="11" fill="#333">Alternative pathway</text>
                    <text x="175" y="310" text-anchor="middle" font-size="11" fill="#333">activation</text>
                    <path d="M 250 285 L 365 200" stroke="#c62828" stroke-width="2" stroke-dasharray="5,5"/>
                    
                    <!-- Resistance Mechanism 4: Gene Amplification -->
                    <rect x="550" y="250" width="150" height="70" fill="#ffcdd2" stroke="#c62828" stroke-width="2" rx="5"/>
                    <text x="625" y="275" text-anchor="middle" font-size="13" font-weight="bold" fill="#c62828">Gene Amplification</text>
                    <text x="625" y="295" text-anchor="middle" font-size="11" fill="#333">Target overexpression</text>
                    <text x="625" y="310" text-anchor="middle" font-size="11" fill="#333">e.g., MET amplification</text>
                    <path d="M 550 285 L 435 200" stroke="#c62828" stroke-width="2" stroke-dasharray="5,5"/>
                </svg>
            </div>
            
            <div class="key-points">
                <h3>Clinical Examples:</h3>
                <ul>
                    <li><strong>EGFR T790M Mutation:</strong> Confers resistance to first-generation EGFR inhibitors in non-small cell lung cancer; detectable through liquid biopsy</li>
                    <li><strong>BCR-ABL Mutations:</strong> Multiple point mutations in chronic myeloid leukemia lead to resistance against tyrosine kinase inhibitors like imatinib</li>
                    <li><strong>MDR1/P-glycoprotein Overexpression:</strong> Increased efflux pump activity reduces intracellular drug concentration in various cancers</li>
                    <li><strong>MSI Status:</strong> Microsatellite instability can predict resistance to certain chemotherapies but sensitivity to immunotherapy</li>
                    <li><strong>Adaptive Resistance:</strong> Dynamic monitoring of emerging resistance markers during treatment enables early intervention strategies</li>
                </ul>
            </div>
        </div>

        <!-- 3. Combination Effects -->
        <div class="detail-section">
            <h2>3. Combination Effects</h2>
            <p>Drug combination therapy aims to enhance treatment efficacy through synergistic interactions while minimizing toxicity. Computational prediction of drug synergy and antagonism helps identify optimal combination regimens, reduce trial-and-error in clinical practice, and accelerate drug development. Understanding interaction mechanisms is crucial for rational combination therapy design.</p>
            
            <div class="diagram">
                <div class="diagram-title">Drug Interaction Types</div>
                <svg width="800" height="320" viewBox="0 0 800 320">
                    <!-- Synergy -->
                    <g>
                        <rect x="50" y="20" width="200" height="120" fill="#c8e6c9" stroke="#2e7d32" stroke-width="2" rx="5"/>
                        <text x="150" y="45" text-anchor="middle" font-size="15" font-weight="bold" fill="#2e7d32">Synergy</text>
                        <text x="150" y="70" text-anchor="middle" font-size="12" fill="#333">Effect(A+B) &gt; Effect(A) + Effect(B)</text>
                        
                        <!-- Graph -->
                        <line x1="70" y1="130" x2="230" y2="130" stroke="#333" stroke-width="1"/>
                        <line x1="70" y1="130" x2="70" y2="70" stroke="#333" stroke-width="1"/>
                        <path d="M 70 120 Q 120 100, 150 85 T 230 75" stroke="#2e7d32" stroke-width="3" fill="none"/>
                        <path d="M 70 120 L 230 95" stroke="#666" stroke-width="1" stroke-dasharray="3,3"/>
                        <text x="100" y="65" font-size="10" fill="#2e7d32">Combined</text>
                        <text x="180" y="90" font-size="10" fill="#666">Expected</text>
                    </g>
                    
                    <!-- Additive -->
                    <g>
                        <rect x="300" y="20" width="200" height="120" fill="#fff9c4" stroke="#f57f17" stroke-width="2" rx="5"/>
                        <text x="400" y="45" text-anchor="middle" font-size="15" font-weight="bold" fill="#f57f17">Additive</text>
                        <text x="400" y="70" text-anchor="middle" font-size="12" fill="#333">Effect(A+B) = Effect(A) + Effect(B)</text>
                        
                        <!-- Graph -->
                        <line x1="320" y1="130" x2="480" y2="130" stroke="#333" stroke-width="1"/>
                        <line x1="320" y1="130" x2="320" y2="70" stroke="#333" stroke-width="1"/>
                        <path d="M 320 120 L 480 80" stroke="#f57f17" stroke-width="3" fill="none"/>
                        <text x="420" y="95" font-size="10" fill="#f57f17">Linear</text>
                    </g>
                    
                    <!-- Antagonism -->
                    <g>
                        <rect x="550" y="20" width="200" height="120" fill="#ffcdd2" stroke="#c62828" stroke-width="2" rx="5"/>
                        <text x="650" y="45" text-anchor="middle" font-size="15" font-weight="bold" fill="#c62828">Antagonism</text>
                        <text x="650" y="70" text-anchor="middle" font-size="12" fill="#333">Effect(A+B) &lt; Effect(A) + Effect(B)</text>
                        
                        <!-- Graph -->
                        <line x1="570" y1="130" x2="730" y2="130" stroke="#333" stroke-width="1"/>
                        <line x1="570" y1="130" x2="570" y2="70" stroke="#333" stroke-width="1"/>
                        <path d="M 570 120 Q 620 115, 650 112 T 730 110" stroke="#c62828" stroke-width="3" fill="none"/>
                        <path d="M 570 120 L 730 90" stroke="#666" stroke-width="1" stroke-dasharray="3,3"/>
                        <text x="600" y="108" font-size="10" fill="#c62828">Combined</text>
                        <text x="680" y="85" font-size="10" fill="#666">Expected</text>
                    </g>
                    
                    <!-- Matrix representation -->
                    <text x="400" y="180" text-anchor="middle" font-size="14" font-weight="bold" fill="#1E64C8">Drug Combination Matrix</text>
                    <g transform="translate(250, 200)">
                        <!-- Grid -->
                        <rect x="0" y="0" width="60" height="60" fill="#c8e6c9" stroke="#333" stroke-width="1"/>
                        <rect x="60" y="0" width="60" height="60" fill="#fff9c4" stroke="#333" stroke-width="1"/>
                        <rect x="120" y="0" width="60" height="60" fill="#ffcdd2" stroke="#333" stroke-width="1"/>
                        <rect x="0" y="60" width="60" height="60" fill="#fff9c4" stroke="#333" stroke-width="1"/>
                        <rect x="60" y="60" width="60" height="60" fill="#c8e6c9" stroke="#333" stroke-width="1"/>
                        <rect x="120" y="60" width="60" height="60" fill="#fff9c4" stroke="#333" stroke-width="1"/>
                        
                        <!-- Labels -->
                        <text x="-10" y="35" text-anchor="end" font-size="11" fill="#333">Drug A</text>
                        <text x="-10" y="95" text-anchor="end" font-size="11" fill="#333">(dose)</text>
                        <text x="90" y="140" text-anchor="middle" font-size="11" fill="#333">Drug B (dose)</text>
                        
                        <!-- Values -->
                        <text x="30" y="35" text-anchor="middle" font-size="10" fill="#2e7d32">+++</text>
                        <text x="90" y="35" text-anchor="middle" font-size="10" fill="#f57f17">++</text>
                        <text x="150" y="35" text-anchor="middle" font-size="10" fill="#c62828">+</text>
                        <text x="30" y="95" text-anchor="middle" font-size="10" fill="#f57f17">++</text>
                        <text x="90" y="95" text-anchor="middle" font-size="10" fill="#2e7d32">+++</text>
                        <text x="150" y="95" text-anchor="middle" font-size="10" fill="#f57f17">++</text>
                    </g>
                </svg>
            </div>
            
            <div class="key-points">
                <h3>Combination Strategies:</h3>
                <ul>
                    <li><strong>Mechanistic Synergy:</strong> Drugs targeting complementary pathways (e.g., BRAF + MEK inhibitors in melanoma) produce enhanced effects</li>
                    <li><strong>Sequential Blockade:</strong> Combining drugs that prevent compensatory resistance mechanisms (e.g., dual HER2 blockade with trastuzumab and pertuzumab)</li>
                    <li><strong>Bliss Independence Model:</strong> Mathematical framework for quantifying synergy by comparing observed vs. expected effects</li>
                    <li><strong>Network-Based Prediction:</strong> Using systems biology approaches to identify optimal drug combinations based on pathway crosstalk</li>
                    <li><strong>High-Throughput Screening:</strong> Large-scale testing of drug combinations combined with ML to predict synergistic pairs</li>
                </ul>
            </div>
        </div>

        <!-- 4. Pharmacogenomics -->
        <div class="detail-section">
            <h2>4. Pharmacogenomics</h2>
            <p>Pharmacogenomics studies how genetic variations affect individual responses to medications, encompassing drug metabolism, efficacy, and adverse reactions. By integrating genomic data with clinical pharmacology, this field enables truly personalized medicine where drug selection and dosing are optimized based on a patient's genetic profile, improving outcomes while reducing toxicity.</p>
            
            <div class="diagram">
                <div class="diagram-title">Pharmacogenomic Pathway</div>
                <svg width="800" height="280" viewBox="0 0 800 280">
                    <!-- Genetic Variants -->
                    <rect x="30" y="60" width="160" height="100" fill="#e1bee7" stroke="#6a1b9a" stroke-width="2" rx="5"/>
                    <text x="110" y="85" text-anchor="middle" font-size="14" font-weight="bold" fill="#6a1b9a">Genetic Variants</text>
                    <text x="110" y="105" text-anchor="middle" font-size="11" fill="#333">CYP2D6 *4/*4</text>
                    <text x="110" y="122" text-anchor="middle" font-size="11" fill="#333">TPMT variants</text>
                    <text x="110" y="139" text-anchor="middle" font-size="11" fill="#333">HLA-B*57:01</text>
                    <text x="110" y="156" text-anchor="middle" font-size="11" fill="#333">VKORC1 -1639G&gt;A</text>
                    
                    <!-- Arrow -->
                    <path d="M 190 110 L 240 110" stroke="#6a1b9a" stroke-width="2" marker-end="url(#arrowhead3)"/>
                    
                    <!-- Drug Metabolism -->
                    <rect x="240" y="20" width="140" height="80" fill="#bbdefb" stroke="#1565c0" stroke-width="2" rx="5"/>
                    <text x="310" y="45" text-anchor="middle" font-size="13" font-weight="bold" fill="#1565c0">Metabolism</text>
                    <text x="310" y="65" text-anchor="middle" font-size="11" fill="#333">↓ Poor metabolizer</text>
                    <text x="310" y="80" text-anchor="middle" font-size="11" fill="#333">↑ Ultra-rapid metabolizer</text>
                    
                    <!-- Arrow -->
                    <path d="M 380 60 L 440 85" stroke="#1565c0" stroke-width="2" marker-end="url(#arrowhead4)"/>
                    
                    <!-- Drug Efficacy -->
                    <rect x="240" y="120" width="140" height="70" fill="#c5e1a5" stroke="#558b2f" stroke-width="2" rx="5"/>
                    <text x="310" y="145" text-anchor="middle" font-size="13" font-weight="bold" fill="#558b2f">Efficacy</text>
                    <text x="310" y="165" text-anchor="middle" font-size="11" fill="#333">Target sensitivity</text>
                    <text x="310" y="180" text-anchor="middle" font-size="11" fill="#333">Response variability</text>
                    
                    <!-- Arrow -->
                    <path d="M 380 155 L 440 130" stroke="#558b2f" stroke-width="2" marker-end="url(#arrowhead5)"/>
                    
                    <!-- Drug Response -->
                    <rect x="440" y="80" width="140" height="70" fill="#fff9c4" stroke="#f57f17" stroke-width="2" rx="5"/>
                    <text x="510" y="105" text-anchor="middle" font-size="14" font-weight="bold" fill="#f57f17">Drug Response</text>
                    <text x="510" y="125" text-anchor="middle" font-size="11" fill="#333">Therapeutic effect</text>
                    <text x="510" y="140" text-anchor="middle" font-size="11" fill="#333">Adverse reactions</text>
                    
                    <!-- Arrow -->
                    <path d="M 580 115 L 620 115" stroke="#f57f17" stroke-width="2" marker-end="url(#arrowhead6)"/>
                    
                    <!-- Clinical Decision -->
                    <rect x="620" y="80" width="140" height="70" fill="#a5d6a7" stroke="#2e7d32" stroke-width="2" rx="5"/>
                    <text x="690" y="105" text-anchor="middle" font-size="14" font-weight="bold" fill="#2e7d32">Clinical Decision</text>
                    <text x="690" y="125" text-anchor="middle" font-size="11" fill="#333">Dose adjustment</text>
                    <text x="690" y="140" text-anchor="middle" font-size="11" fill="#333">Alternative drug</text>
                    
                    <!-- Adverse Effects -->
                    <rect x="240" y="210" width="140" height="50" fill="#ffcdd2" stroke="#c62828" stroke-width="2" rx="5"/>
                    <text x="310" y="230" text-anchor="middle" font-size="13" font-weight="bold" fill="#c62828">Toxicity Risk</text>
                    <text x="310" y="248" text-anchor="middle" font-size="11" fill="#333">ADR susceptibility</text>
                    
                    <!-- Arrow -->
                    <path d="M 380 235 L 440 175" stroke="#c62828" stroke-width="2" marker-end="url(#arrowhead7)"/>
                    
                    <!-- Arrowhead definitions -->
                    <defs>
                        <marker id="arrowhead3" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <polygon points="0 0, 10 3, 0 6" fill="#6a1b9a" />
                        </marker>
                        <marker id="arrowhead4" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <polygon points="0 0, 10 3, 0 6" fill="#1565c0" />
                        </marker>
                        <marker id="arrowhead5" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <polygon points="0 0, 10 3, 0 6" fill="#558b2f" />
                        </marker>
                        <marker id="arrowhead6" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <polygon points="0 0, 10 3, 0 6" fill="#f57f17" />
                        </marker>
                        <marker id="arrowhead7" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <polygon points="0 0, 10 3, 0 6" fill="#c62828" />
                        </marker>
                    </defs>
                </svg>
            </div>
            
            <div class="key-points">
                <h3>Clinical Applications:</h3>
                <ul>
                    <li><strong>CYP450 Polymorphisms:</strong> CYP2D6, CYP2C19, and CYP2C9 variants dramatically affect metabolism of ~25% of commonly prescribed drugs, guiding dosing for antidepressants, anticoagulants, and pain medications</li>
                    <li><strong>Warfarin Dosing:</strong> VKORC1 and CYP2C9 genotypes enable precise warfarin dosing algorithms, reducing bleeding risks and improving anticoagulation control</li>
                    <li><strong>HLA-Based ADR Prevention:</strong> HLA-B*57:01 screening prevents abacavir hypersensitivity; HLA-B*15:02 testing avoids carbamazepine-induced Stevens-Johnson syndrome</li>
                    <li><strong>Thiopurine Methyltransferase (TPMT):</strong> Testing identifies patients at high risk for severe myelosuppression from azathioprine or mercaptopurine</li>
                    <li><strong>Oncology Applications:</strong> DPYD variants predict fluoropyrimidine toxicity; UGT1A1*28 guides irinotecan dosing</li>
                </ul>
            </div>
        </div>

        <!-- 5. Clinical Trials -->
        <div class="detail-section">
            <h2>5. Clinical Trials</h2>
            <p>Integration of drug response prediction into clinical trial design represents a paradigm shift toward precision medicine. By leveraging biomarkers, genomic data, and predictive algorithms, modern trials can identify patient populations most likely to benefit from experimental therapies, employ adaptive designs, and accelerate drug approval processes while improving success rates and reducing costs.</p>
            
            <div class="diagram">
                <div class="diagram-title">Precision Medicine Clinical Trial Design</div>
                <svg width="800" height="340" viewBox="0 0 800 340">
                    <!-- Traditional vs Precision Trial -->
                    <g>
                        <!-- Traditional Trial -->
                        <text x="150" y="25" text-anchor="middle" font-size="14" font-weight="bold" fill="#666">Traditional Trial</text>
                        <rect x="50" y="40" width="200" height="50" fill="#e0e0e0" stroke="#666" stroke-width="2" rx="5"/>
                        <text x="150" y="70" text-anchor="middle" font-size="12" fill="#333">All Patients (n=1000)</text>
                        
                        <path d="M 150 90 L 150 120" stroke="#666" stroke-width="2" marker-end="url(#arrowhead8)"/>
                        
                        <rect x="50" y="120" width="90" height="50" fill="#ffcdd2" stroke="#c62828" stroke-width="2" rx="5"/>
                        <text x="95" y="140" text-anchor="middle" font-size="11" fill="#333">Non-</text>
                        <text x="95" y="155" text-anchor="middle" font-size="11" fill="#333">responders</text>
                        <text x="95" y="165" text-anchor="middle" font-size="10" font-weight="bold" fill="#c62828">70%</text>
                        
                        <rect x="160" y="120" width="90" height="50" fill="#c8e6c9" stroke="#2e7d32" stroke-width="2" rx="5"/>
                        <text x="205" y="145" text-anchor="middle" font-size="11" fill="#333">Responders</text>
                        <text x="205" y="165" text-anchor="middle" font-size="10" font-weight="bold" fill="#2e7d32">30%</text>
                    </g>
                    
                    <g>
                        <!-- Precision Trial -->
                        <text x="550" y="25" text-anchor="middle" font-size="14" font-weight="bold" fill="#1E64C8">Precision Trial</text>
                        <rect x="450" y="40" width="200" height="50" fill="#e3f2fd" stroke="#1E64C8" stroke-width="2" rx="5"/>
                        <text x="550" y="65" text-anchor="middle" font-size="12" fill="#333">Biomarker Screening</text>
                        <text x="550" y="80" text-anchor="middle" font-size="11" fill="#333">(n=1000)</text>
                        
                        <path d="M 500 90 L 470 120" stroke="#c62828" stroke-width="2" marker-end="url(#arrowhead9)"/>
                        <path d="M 600 90 L 630 120" stroke="#2e7d32" stroke-width="2" marker-end="url(#arrowhead10)"/>
                        
                        <rect x="380" y="120" width="110" height="50" fill="#eeeeee" stroke="#757575" stroke-width="2" rx="5"/>
                        <text x="435" y="140" text-anchor="middle" font-size="11" fill="#333">Biomarker</text>
                        <text x="435" y="155" text-anchor="middle" font-size="11" fill="#333">Negative</text>
                        <text x="435" y="165" text-anchor="middle" font-size="10" fill="#757575">Excluded</text>
                        
                        <rect x="510" y="120" width="140" height="50" fill="#e8f5e9" stroke="#2e7d32" stroke-width="2" rx="5"/>
                        <text x="580" y="135" text-anchor="middle" font-size="11" fill="#333">Biomarker Positive</text>
                        <text x="580" y="150" text-anchor="middle" font-size="11" fill="#333">Enrolled (n=300)</text>
                        <text x="580" y="165" text-anchor="middle" font-size="10" font-weight="bold" fill="#2e7d32">Response: 75%</text>
                    </g>
                    
                    <!-- Study Components -->
                    <text x="400" y="210" text-anchor="middle" font-size="15" font-weight="bold" fill="#1E64C8">Key Trial Components</text>
                    
                    <g transform="translate(100, 230)">
                        <!-- Companion Diagnostics -->
                        <rect x="0" y="0" width="140" height="60" fill="#e1f5fe" stroke="#0277bd" stroke-width="2" rx="5"/>
                        <text x="70" y="22" text-anchor="middle" font-size="12" font-weight="bold" fill="#0277bd">Companion</text>
                        <text x="70" y="37" text-anchor="middle" font-size="12" font-weight="bold" fill="#0277bd">Diagnostics</text>
                        <text x="70" y="52" text-anchor="middle" font-size="10" fill="#333">Biomarker tests</text>
                        
                        <!-- Adaptive Design -->
                        <rect x="160" y="0" width="140" height="60" fill="#f3e5f5" stroke="#7b1fa2" stroke-width="2" rx="5"/>
                        <text x="230" y="22" text-anchor="middle" font-size="12" font-weight="bold" fill="#7b1fa2">Adaptive</text>
                        <text x="230" y="37" text-anchor="middle" font-size="12" font-weight="bold" fill="#7b1fa2">Design</text>
                        <text x="230" y="52" text-anchor="middle" font-size="10" fill="#333">Dynamic enrollment</text>
                        
                        <!-- Real-World Data -->
                        <rect x="320" y="0" width="140" height="60" fill="#fff3e0" stroke="#e65100" stroke-width="2" rx="5"/>
                        <text x="390" y="22" text-anchor="middle" font-size="12" font-weight="bold" fill="#e65100">Real-World</text>
                        <text x="390" y="37" text-anchor="middle" font-size="12" font-weight="bold" fill="#e65100">Evidence</text>
                        <text x="390" y="52" text-anchor="middle" font-size="10" fill="#333">Post-approval data</text>
                        
                        <!-- Master Protocols -->
                        <rect x="480" y="0" width="140" height="60" fill="#e8f5e9" stroke="#2e7d32" stroke-width="2" rx="5"/>
                        <text x="550" y="22" text-anchor="middle" font-size="12" font-weight="bold" fill="#2e7d32">Master</text>
                        <text x="550" y="37" text-anchor="middle" font-size="12" font-weight="bold" fill="#2e7d32">Protocols</text>
                        <text x="550" y="52" text-anchor="middle" font-size="10" fill="#333">Basket/Umbrella</text>
                    </g>
                    
                    <!-- Arrowhead definitions -->
                    <defs>
                        <marker id="arrowhead8" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <polygon points="0 0, 10 3, 0 6" fill="#666" />
                        </marker>
                        <marker id="arrowhead9" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <polygon points="0 0, 10 3, 0 6" fill="#c62828" />
                        </marker>
                        <marker id="arrowhead10" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <polygon points="0 0, 10 3, 0 6" fill="#2e7d32" />
                        </marker>
                    </defs>
                </svg>
            </div>
            
            <div class="key-points">
                <h3>Modern Trial Innovations:</h3>
                <ul>
                    <li><strong>Basket Trials:</strong> Enroll patients with the same biomarker across different tumor types (e.g., NCI-MATCH, targeting specific mutations regardless of cancer origin)</li>
                    <li><strong>Umbrella Trials:</strong> Test multiple targeted therapies in a single disease type based on different biomarkers (e.g., Lung-MAP for non-small cell lung cancer)</li>
                    <li><strong>Adaptive Trial Designs:</strong> Allow protocol modifications based on interim results, improving efficiency and ethical patient allocation</li>
                    <li><strong>Companion Diagnostics:</strong> Co-develop diagnostic tests with therapeutics to identify appropriate patient populations (e.g., PD-L1 testing for checkpoint inhibitors)</li>
                    <li><strong>Digital Biomarkers:</strong> Incorporate wearable devices and remote monitoring to track real-time response and adverse events</li>
                    <li><strong>Platform Trials:</strong> Perpetual trials that can add or drop treatment arms based on performance, accelerating multiple drug evaluations simultaneously</li>
                </ul>
            </div>
        </div>

    </div>
</body>
</html>